항-GD2 항체, 면역접합체 및 그의 치료적 용도

본 발명은 인간 GD2 단백질에 결합하는 항체, 뿐만 아니라 상기 항체를 코딩하는 서열을 포함하는 단리된 핵산 및 숙주 세포를 제공한다. 본 발명은 또한 성장 억제제에 연결된 상기 항체를 포함하는 면역접합체, 및 본 발명의 항체 또는 면역접합체를 포함하는 제약 조성물을 제공한다. 본 발명은 또한 암 치료 또는 진단 목적을 위한 본 발명의 항체, 면역접합체 및 제약 조성물의 용도를 제공한다. The invention provides antibodies which bind human GD2 protein, as well as isola...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SLOOT WILLEM, GROSS ALEC, MA JIANGUO, ANDERL JAN, RASCHE NICOLAS, DOTTERWEICH JULIA, SHAN MIN, AMENDT CHRISTIANE, MCKENNA SEAN D
Format: Patent
Sprache:kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SLOOT WILLEM
GROSS ALEC
MA JIANGUO
ANDERL JAN
RASCHE NICOLAS
DOTTERWEICH JULIA
SHAN MIN
AMENDT CHRISTIANE
MCKENNA SEAN D
description 본 발명은 인간 GD2 단백질에 결합하는 항체, 뿐만 아니라 상기 항체를 코딩하는 서열을 포함하는 단리된 핵산 및 숙주 세포를 제공한다. 본 발명은 또한 성장 억제제에 연결된 상기 항체를 포함하는 면역접합체, 및 본 발명의 항체 또는 면역접합체를 포함하는 제약 조성물을 제공한다. 본 발명은 또한 암 치료 또는 진단 목적을 위한 본 발명의 항체, 면역접합체 및 제약 조성물의 용도를 제공한다. The invention provides antibodies which bind human GD2 protein, as well as isolated nucleic acids and host cells comprising a sequence encoding said antibodies. The invention also provides immunoconjugates comprising said antibodies linked to a growth-inhibitory agent, and pharmaceutical compositions comprising antibodies or immunoconjugates of the invention. The invention also provides use of the antibodies, immunoconjugates and pharmaceutical compositions of the invention for the treatment of cancer or for diagnostic purposes.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20240155334A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20240155334A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20240155334A3</originalsourceid><addsrcrecordid>eNrjZLB-O3WtrruLkQKQfrNpi47C65Vb3kxf-2bBxLdTVwIFFF5v6Fd4tX3Hm7kzFN7snPF6cc-bBY0Kb2atfN3fwsPAmpaYU5zKC6W5GZTdXEOcPXRTC_LjU4sLEpNT81JL4r2DjAyMTAwMTU2NjU0cjYlTBQAzMT7F</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>항-GD2 항체, 면역접합체 및 그의 치료적 용도</title><source>esp@cenet</source><creator>SLOOT WILLEM ; GROSS ALEC ; MA JIANGUO ; ANDERL JAN ; RASCHE NICOLAS ; DOTTERWEICH JULIA ; SHAN MIN ; AMENDT CHRISTIANE ; MCKENNA SEAN D</creator><creatorcontrib>SLOOT WILLEM ; GROSS ALEC ; MA JIANGUO ; ANDERL JAN ; RASCHE NICOLAS ; DOTTERWEICH JULIA ; SHAN MIN ; AMENDT CHRISTIANE ; MCKENNA SEAN D</creatorcontrib><description>본 발명은 인간 GD2 단백질에 결합하는 항체, 뿐만 아니라 상기 항체를 코딩하는 서열을 포함하는 단리된 핵산 및 숙주 세포를 제공한다. 본 발명은 또한 성장 억제제에 연결된 상기 항체를 포함하는 면역접합체, 및 본 발명의 항체 또는 면역접합체를 포함하는 제약 조성물을 제공한다. 본 발명은 또한 암 치료 또는 진단 목적을 위한 본 발명의 항체, 면역접합체 및 제약 조성물의 용도를 제공한다. The invention provides antibodies which bind human GD2 protein, as well as isolated nucleic acids and host cells comprising a sequence encoding said antibodies. The invention also provides immunoconjugates comprising said antibodies linked to a growth-inhibitory agent, and pharmaceutical compositions comprising antibodies or immunoconjugates of the invention. The invention also provides use of the antibodies, immunoconjugates and pharmaceutical compositions of the invention for the treatment of cancer or for diagnostic purposes.</description><language>kor</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241028&amp;DB=EPODOC&amp;CC=KR&amp;NR=20240155334A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241028&amp;DB=EPODOC&amp;CC=KR&amp;NR=20240155334A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SLOOT WILLEM</creatorcontrib><creatorcontrib>GROSS ALEC</creatorcontrib><creatorcontrib>MA JIANGUO</creatorcontrib><creatorcontrib>ANDERL JAN</creatorcontrib><creatorcontrib>RASCHE NICOLAS</creatorcontrib><creatorcontrib>DOTTERWEICH JULIA</creatorcontrib><creatorcontrib>SHAN MIN</creatorcontrib><creatorcontrib>AMENDT CHRISTIANE</creatorcontrib><creatorcontrib>MCKENNA SEAN D</creatorcontrib><title>항-GD2 항체, 면역접합체 및 그의 치료적 용도</title><description>본 발명은 인간 GD2 단백질에 결합하는 항체, 뿐만 아니라 상기 항체를 코딩하는 서열을 포함하는 단리된 핵산 및 숙주 세포를 제공한다. 본 발명은 또한 성장 억제제에 연결된 상기 항체를 포함하는 면역접합체, 및 본 발명의 항체 또는 면역접합체를 포함하는 제약 조성물을 제공한다. 본 발명은 또한 암 치료 또는 진단 목적을 위한 본 발명의 항체, 면역접합체 및 제약 조성물의 용도를 제공한다. The invention provides antibodies which bind human GD2 protein, as well as isolated nucleic acids and host cells comprising a sequence encoding said antibodies. The invention also provides immunoconjugates comprising said antibodies linked to a growth-inhibitory agent, and pharmaceutical compositions comprising antibodies or immunoconjugates of the invention. The invention also provides use of the antibodies, immunoconjugates and pharmaceutical compositions of the invention for the treatment of cancer or for diagnostic purposes.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB-O3WtrruLkQKQfrNpi47C65Vb3kxf-2bBxLdTVwIFFF5v6Fd4tX3Hm7kzFN7snPF6cc-bBY0Kb2atfN3fwsPAmpaYU5zKC6W5GZTdXEOcPXRTC_LjU4sLEpNT81JL4r2DjAyMTAwMTU2NjU0cjYlTBQAzMT7F</recordid><startdate>20241028</startdate><enddate>20241028</enddate><creator>SLOOT WILLEM</creator><creator>GROSS ALEC</creator><creator>MA JIANGUO</creator><creator>ANDERL JAN</creator><creator>RASCHE NICOLAS</creator><creator>DOTTERWEICH JULIA</creator><creator>SHAN MIN</creator><creator>AMENDT CHRISTIANE</creator><creator>MCKENNA SEAN D</creator><scope>EVB</scope></search><sort><creationdate>20241028</creationdate><title>항-GD2 항체, 면역접합체 및 그의 치료적 용도</title><author>SLOOT WILLEM ; GROSS ALEC ; MA JIANGUO ; ANDERL JAN ; RASCHE NICOLAS ; DOTTERWEICH JULIA ; SHAN MIN ; AMENDT CHRISTIANE ; MCKENNA SEAN D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20240155334A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SLOOT WILLEM</creatorcontrib><creatorcontrib>GROSS ALEC</creatorcontrib><creatorcontrib>MA JIANGUO</creatorcontrib><creatorcontrib>ANDERL JAN</creatorcontrib><creatorcontrib>RASCHE NICOLAS</creatorcontrib><creatorcontrib>DOTTERWEICH JULIA</creatorcontrib><creatorcontrib>SHAN MIN</creatorcontrib><creatorcontrib>AMENDT CHRISTIANE</creatorcontrib><creatorcontrib>MCKENNA SEAN D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SLOOT WILLEM</au><au>GROSS ALEC</au><au>MA JIANGUO</au><au>ANDERL JAN</au><au>RASCHE NICOLAS</au><au>DOTTERWEICH JULIA</au><au>SHAN MIN</au><au>AMENDT CHRISTIANE</au><au>MCKENNA SEAN D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>항-GD2 항체, 면역접합체 및 그의 치료적 용도</title><date>2024-10-28</date><risdate>2024</risdate><abstract>본 발명은 인간 GD2 단백질에 결합하는 항체, 뿐만 아니라 상기 항체를 코딩하는 서열을 포함하는 단리된 핵산 및 숙주 세포를 제공한다. 본 발명은 또한 성장 억제제에 연결된 상기 항체를 포함하는 면역접합체, 및 본 발명의 항체 또는 면역접합체를 포함하는 제약 조성물을 제공한다. 본 발명은 또한 암 치료 또는 진단 목적을 위한 본 발명의 항체, 면역접합체 및 제약 조성물의 용도를 제공한다. The invention provides antibodies which bind human GD2 protein, as well as isolated nucleic acids and host cells comprising a sequence encoding said antibodies. The invention also provides immunoconjugates comprising said antibodies linked to a growth-inhibitory agent, and pharmaceutical compositions comprising antibodies or immunoconjugates of the invention. The invention also provides use of the antibodies, immunoconjugates and pharmaceutical compositions of the invention for the treatment of cancer or for diagnostic purposes.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language kor
recordid cdi_epo_espacenet_KR20240155334A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 항-GD2 항체, 면역접합체 및 그의 치료적 용도
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T09%3A23%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SLOOT%20WILLEM&rft.date=2024-10-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20240155334A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true